Ruplizumab, CAS 220651-94-5

Product Description: Ruplizumab (BG 9588) is a humanized monoclonal anti-CD40L (TNF Receptor) IgG1κ antibody. Ruplizumab has the potential for systemic lupus erythematosus disease research[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Chris Chamberlain, et al. Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles. Ann Rheum Dis. 2017 Nov;76(11):1837-1844.

CAS Number: 220651-94-5

Molecular Weight: N/A

Compound Purity: 99.84

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: TNF Receptor

• Artikelnummer: MEXHY-P99315-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99315-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK